{"id":"W4307130134","doi":"10.51731/cjht.2022.478","title":"Ruxolitinib (Jakavi)","year":2022,"lang":"en","type":"article","venue":"Canadian Journal of Health Technologies","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Ruxolitinib; Medicine; Family medicine; Drug; Pharmacology; Internal medicine; Political science; Health care; Myelofibrosis","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005637946,0.0002880743,0.0003023008,0.0008161367,0.0002496192,0.0009670454,0.0003907696,0.000442536,0.01561032],"category_scores_gemma":[0.0008680654,0.00008337017,0.0003994684,0.0006121137,0.0002588947,0.0004981637,0.0003903855,0.0005727821,0.004121081],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0013149,"about_ca_system_score_gemma":0.001934013,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0135582,"about_ca_topic_score_gemma":0.0449343,"domain_scores_codex":[0.9996245,0.00007239213,0.00004064155,0.00004909521,0.0001601598,0.0000531622],"domain_scores_gemma":[0.999661,0.00006245429,0.0001005922,0.00001211109,0.0001265366,0.00003728754],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002738148,0.00004025317,0.000629098,0.002948553,0.00007872647,0.0001052108,0.00002773844,0.0001134047,0.002509104,0.002999546,0.1013109,0.8889636],"study_design_scores_gemma":[0.0001118235,0.0002615725,0.003395297,0.001868275,0.0001203625,0.0005553951,0.00003104016,0.00009744301,0.002688328,0.0003906085,0.9904665,0.00001337937],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.008288004,0.8115131,0.001483273,0.009836032,0.001637371,0.0001818225,0.002711152,0.0003427031,0.1640066],"genre_scores_gemma":[0.1303861,0.7172322,0.004892582,0.01216886,0.001280139,0.000188555,0.004891786,0.00005741047,0.1289024],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01561032,"threshold_uncertainty_score":0.05222166,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04092840541870764,"score_gpt":0.3241599007891345,"score_spread":0.2832314953704269,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}